Changeflow GovPing Healthcare & Life Sciences National Heart, Lung, and Blood Advisory Counci...
Routine Notice Added Final

National Heart, Lung, and Blood Advisory Council Notice of Open Meeting

Favicon for www.federalregister.gov FR: Health and Human Services Department
Published
Detected
Email

Summary

The National Heart, Lung, and Blood Advisory Council will hold an open meeting on June 9, 2026, from 8:30 a.m. to 12:00 p.m. at the National Institutes of Health Claude D. Pepper Building in Bethesda, MD. The session will address program policies and issues and is open to the public with attendance limited to space available. Individuals requiring special assistance such as sign language interpretation must notify the Contact Person at least 10 days prior to the meeting.

“The meeting will be open to the public, with attendance limited to space available.”

Published by Health and Human Services Department on federalregister.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors FR: Health and Human Services Department for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 57 changes logged to date.

What changed

This Federal Register notice announces an open meeting of the National Heart, Lung, and Blood Advisory Council scheduled for June 9, 2026, from 8:30 a.m. to 12:00 p.m. at the NIH Claude D. Pepper Building in Bethesda, MD. The meeting is open to the public for attendance and oral comment participation, with individuals needing special assistance required to notify the Contact Person at least 10 days in advance. The open session will also be accessible via NIH Videocasting and Podcasting.

Affected parties include healthcare providers, researchers, and patient advocates interested in heart, lung, and blood disease research programs who wish to attend or present oral comments. Interested presenters must submit a letter of intent and brief organization description to the Contact Person at least 10 days before the meeting. All visitors to NIH facilities must present government-issued photo identification and state the purpose of their visit.

Hearing

Date
2026-06-09 at 08:30 – 12:00
Location
Bethesda, MD

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Notice

National Heart, Lung, and Blood Institute; Notice of Open Meeting

A Notice by the National Institutes of Health on 04/23/2026

  • PDF

  • Document Details

  • Document Dates

- Table of Contents

  • Public Comments
  • Regulations.gov Data

- Sharing

  • Print
  • Other Formats
  • Public Inspection Published Document: 2026-07911 (91 FR 21831) Document Headings ###### Department of Health and Human Services
National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Heart, Lung, and Blood Advisory Council.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website at https://www.nhlbi.nih.gov/​about/​advisory-and-peer-review-committees/​advisory-council.

Name of Committee: National Heart, Lung, and Blood Advisory Council.

Date: June 9, 2026.

Open: 8:30 a.m. to 12:00 p.m.

Agenda: To discuss program policies and issues.

Place: National Institutes of Health, Claude D. Pepper Building, 31 Center Drive, Bethesda, MD 20894.

Meeting Format: In-Person.

Contact Person: Charisee Lamar, Ph.D., M.P.H., R.R.T., Director, Division of Extramural Research Activities, National Heart, Lung, and Blood Institute, National Institutes of Health, 6705 Rockledge Drive, Room 206-Q, Bethesda, MD 20892, 301-827-5517, lamarc@mail.nih.gov.

Registration is not required to attend the open portion of this meeting.

Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.

In the interest of security, NIH has procedures at https://security.nih.gov/​visitors/​Pages/​visitor-campus-access.aspx for entrance into on-campus and off-campus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a government-issued photo ID, driver's license, or passport) and to state the purpose of their visit.

Information is also available on the Institute's/Center's home page: https://www.nhlbi.nih.gov/​about/​advisory-and-peer-review-committees/​advisory-council where an agenda and any additional information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

Dated: April 21, 2026.

Denise M. Santeufemio,

Supervisory Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2026-07911 Filed 4-22-26; 8:45 am]

BILLING CODE 4167-05-P

Published Document: 2026-07911 (91 FR 21831)

Named provisions

National Heart, Lung, and Blood Advisory Council

Get daily alerts for FR: Health and Human Services Department

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Health and Human Services Department.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Health and Human Services Department
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
91 FR 21831

Who this affects

Applies to
Government agencies Healthcare providers
Industry sector
6211 Healthcare Providers
Activity scope
Advisory committee meetings Research program oversight
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Regulatory Affairs
Topics
Pharmaceuticals Medical Devices Public Health

Get alerts for this source

We'll email you when FR: Health and Human Services Department publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!